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SUMMARY
Fetal hydrops (hydrops fetalis) remains a significant cause offetal and neonatal
mortality. The decreased incidence of rhesus iso-immunisation due to prophy-
laxis with rhesus immune globulin (anti-D), improved antenatal ultrasound
screening, and advances in neonatal intensive care have greatly altered the
clinical outlook in this condition. A retrospective review ofall 27 liveborn cases
of hydrops in the Royal Maternity Hospital, Belfast in the period 1974-89
showed that in the lastfive years 40% ofcases were non-immune in origin. The
mortality rate fellfrom 100% in the firstpart ofthe study to 50% in the second.
INTRODUCTION
There have been two major changes in the management of fetal hydrops in the
last twenty years - the use of anti-D immunoprophylaxis which has greatly
reduced the incidence of the disease and the development of perinatal intensive
care. This has led to major changes in both the prenatal and postnatal manage-
ment ofthe gravely ill fetus. We reviewed the records of all liveborn cases offetal
hydrops in the Royal Maternity Hospital, Belfast in the period 1974-89 to assess
changes in aetiology, incidence, management, and prognosis.
METHODS
Fetal hydrops was defined as fluid accumulation in some or all serous cavities
(peritoneal, pericardial, and pleural) with generalised skin and placental oedema.
In the 15 year period 1974-89, there were 27 liveborn babies with hydrops
among the 52,177 liveborn babies in the Royal Maternity Hospital, an incidence
of 1 in 1932. We chose not to include stillbirths because in some cases a full
assessment to ascertain cause had not been performed.
RESULTS
The specialised neonatal intensive care unit was opened in this hospital in 1978;
we looked at babies managed before and after this date (Table). Ofthe 11 babies
born in 1974-7 there were no survivors. In this early period, 10 were due to
rhesus-D incompatibility, one to rhesus-E incompatibility, and none to other
blood group incompatibilities or non-immune causes. The management of the
cases of iso-immunisation, both pre- and post-natal, is outlined in the Table.
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TABLE
Clinical details and management of27 cases offetal hydrops
Number of babies
Gestational age (weeks) (mean ± SD)
Birth weight (g) (mean ± SD)
Cause
Rhesus-D
Rhesus non-D
Other iso-immunisation
Non -immune
Mortality - all causes (%)
1974-7
11
28-9 ± 3-2
1607 ± 741
10 ( 91%)
1 ( 9%)
0
0
11 (100%)
1978-89
16
30-9 ± 4.3
1975 ± 802
10
1
1
4
(63%)
( 6%)
( 6%)
(25%)
8 (50%)
Management ofbabies with iso-immunisation
Number
Intra-uterine fetal transfusion
Exchange transfusion
Died in labour ward
Mechanical ventilation
Mortality (%)
11
5 ( 45%)
10 ( 91%)
1 ( 9%)
0
11 (100%)
12
5 (42%)
10 (83%)
1 ( 8%)
11
7 (58%)
In the later period, half of the babies with hydrops survived. Ten were due to
rhesus-D incompatibility, 1 to combined rhesus - c and E antibodies, 1 to Kells
antibody, and 4 to non.immune causes. The managementofthe fourbabies with
non -immune hydrops included mechanical ventilation (in three), thoracocentesis
(in two), paracentesis (in one), and treatment with digoxin and diuretics (inthree).
These cases were due to congenital cytomegalovirus infection, chronic feto -
maternal transfusion, congenital heart disease (Ebstein's anomaly) and no cause
was found after extensive investigation of the fourth leaving a diagnosis of
idiopathic non -immune hydrops. Three survived, one with a mild residual
hemiplegia.
DISCUSSION
In the past, the vast majority of cases of hydrops were due to iso -immunisation.
Non-immune hydrops was first described in 1943 by Potter,' who defined it as
hydrops due to any cause other than feto -maternal blood group incompatibility.
Priorto1970, Macafee2 reportedthat17% ofcasesofhydrops werenon -immune
in origin. In the last five years of our study, 40% of cases were non-immune,
which has also been the experience of others.3 Since the introduction of anti -D
prophylaxis, an increasing number of cases of materno-fetal blood group
incompatibility are due to groups other than rhesus-D. We have had cases of
hydrops due to rhesus-E, rhesus-c, and Kells blood groups. O'Sullivan4 found
that the proportion of patients delivered in the Royal Maternity Hospital, Belfast
with antibodies otherthan rhesus-D had risen from 11 % in 1970 to 37% in 1980.
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Hydrops has many causes, and new ones are reported every year. In a review by
Machin3 of 1414 cases published in the 1980's, 63% were due to five fetal
disease processes: cardiovascular disorder, chromosome abnormalities, thoracic
disorder, twin-twin transfusion, and anaemia. Formerly, the appearance of
hydrops was considered to be a very poor prognostic factor in cases of iso-
immunisation withdeath almost inevitable.5 Recently, theprognosishasimproved
- we report a mortality rate of 50% in cases of rhesus iso-immunisation in the
last eight years, and others have reported rates as low as 25%.6 For non-immune
hydrops our mortality rate was 25%, which compares favourably with reports
of rates up to 80-95%.7,8 The change in prognosis for the hydropic fetus is
probably due to many factors, including delivery ofthe hydropic infant by elective
caesarean section in a controlled setting with a neonatal team in attendance to
perform intensive resuscitation.9
The prenatal diagnosis of hydrops is improving due to the use of high resolution
ultrasound scanning. In the last eight years all cases of hydrops in pregnancies
complicated by iso-immunisation were identified in the antenatal period so
that management could be planned in advance. However, only 50% of our cases
of non-immune hydrops were identified prior to birth. It has been suggested
that certain maternal conditions can be used to predict the presence of non-
immune hydrops. In one report, if maternal anaemia, hypertension or poly-
hydramnios had been used as indications for ultrasound examination, 80% of
babies ofgreaterthan 28 weeks gestation with non-immune hydrops would have
been detected.8 If these criteria had been applied to our babies, all would have
been identified prior to birth.
In the future, it is probable that the mortality rate in fetal hydrops will continue to
fall due to better antenatal detection and more widespread use of cordocentesis
for direct fetal intravascular transfusion in severe haemolytic disease.'0 Forthis to
be achieved, the obstetrician must be alert to the possibility of this disease.
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